- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06677073
Effects of FATmax Exercise and HIIT on Fat Loss in Overweight Young Women
November 5, 2024 updated by: Beijing Sport University
Effects of Maximal Fat Oxidation Exercise and High-intensity Interval Training on Fat Loss in Overweight Young Women
This study investigated the effects of two exercise modalities: high-intensity interval training (HIIT) and maximal fat oxidation (FATmax) exercise on fat loss in overweight young women.
Participants were randomly assigned to either the HIIT or FATmax group, underwent an 8-week supervised exercise intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study aims to compare the effects of HIIT and FATmax exercise on fat loss in overweight young women.
Participants were recruited and randomly assigned to either the HIIT group or the FATmax group.
The intervention lasted for 8 weeks, during which participants maintained their usual diet.
Both body morphology and body composition were assessed before and after the intervention.
In order to recommend exercise strategy for overweight young women reduce fat and improve their health.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China
- School of Sports Medicine and Rehabilitation, Beijing Sport University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Female, aged between 18 and 30 years.
- Overweight, BMI greater than 24.0 kg·m-2.
- Participants Lack of exercise habits.
- Participants Without significant fluctuation in weight.
Exclusion Criteria:
- Participants took drugs affecting metabolism and hormones during the experimental period.
- Participants had a history of oral weight loss pills and contraceptive pills.
- Participants had a history of smoking, alcohol consumption, or daily consumption of caffeine-containing beverages.
- Participants had cardiovascular or basal metabolic disorders, such as hypertension, coronary heart disease, or diabetes mellitus.
- Participants had other acute or chronic injuries related to exercise.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HIIT group
|
High-intensity interval training
|
|
Experimental: FATmax group
|
Maximal fat oxidation exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body weight
Time Frame: 8 weeks
|
The change of body weight before and after intervention.
|
8 weeks
|
|
Body mass index (BMI)
Time Frame: 8 weeks
|
The change of body mass index before and after intervention.
|
8 weeks
|
|
Waist circumference
Time Frame: 8 weeks
|
The change of waist circumference before and after intervention.
|
8 weeks
|
|
Hip circumference
Time Frame: 8 weeks
|
The change of hip circumference before and after intervention.
|
8 weeks
|
|
Body fat weight
Time Frame: 8 weeks
|
The change of body fat weight before and after intervention.
|
8 weeks
|
|
Body fat percentage
Time Frame: 8 weeks
|
The change of body fat percentage before and after intervention.
|
8 weeks
|
|
Visceral fat area
Time Frame: 8 weeks
|
The change of visceral fat area before and after intervention.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height
Time Frame: 8 weeks
|
The change of height before and after intervention.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 15, 2021
Primary Completion (Actual)
September 30, 2021
Study Completion (Actual)
December 30, 2021
Study Registration Dates
First Submitted
November 5, 2024
First Submitted That Met QC Criteria
November 5, 2024
First Posted (Actual)
November 6, 2024
Study Record Updates
Last Update Posted (Actual)
November 6, 2024
Last Update Submitted That Met QC Criteria
November 5, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EOMFOEAHITOFLIOYW
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Carmen Lucas AbellánUniversidad Católica San Antonio de MurciaCompletedOverweight/Obesity | Overweight or Obese | Overweight or Obese Adults | Obesity and Overweight | Obese SubjectsSpain
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Empros Pharma ABNot yet recruitingOverweight or Obese | Obesity and Overweight
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
Children's Hospital Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight, Childhood | Overweight, InfantFrance
-
Medialis Ltd.RecruitingObesity & Overweight | Overweight (BMI > 25)United Kingdom
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Federal University of Health Science of Porto AlegreCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Active, not recruitingObesity & Overweight | Overweight (BMI > 25)Brazil
Clinical Trials on High-intensity interval training
-
University of MichiganCompletedGlucose IntoleranceUnited States
-
Universidad SurcolombianaMaciste Macias; Gilberto AstaizaRecruiting
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland
-
Riphah International UniversityCompleted
-
Cairo UniversityKasr El Aini HospitalCompletedDiabetes Mellitus, Type 2Egypt
-
Universidad Santo TomasCompletedMetabolic DiseasesColombia
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Wu JiarunCompletedBurnout,Motivation,Stress,Mental ToughnessMalaysia
-
Cairo UniversityRecruiting